S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Micron Solutions, Inc. stock logo
MICR
Micron Solutions
$1.25
$1.10
$0.56
$2.45
$4.30M0.0129,500 shsN/A
Nuwellis, Inc. stock logo
NUWE
Nuwellis
$0.26
$0.46
$0.24
$5.73
$1.75M0.17737,770 shs236,196 shs
Positron Co. stock logo
POSC
Positron
$1.15
$1.28
$0.87
$1.97
$29.82M0.985,004 shs100 shs
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
$0.86
+1.2%
$0.92
$0.65
$1.59
$13.68M0.2228,102 shs8,957 shs
Viveve Medical, Inc. stock logo
VIVE
Viveve Medical
$0.00
$0.00
$0.00
$0.11
$2K0.083,365 shs1,404 shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Micron Solutions, Inc. stock logo
MICR
Micron Solutions
0.00%0.00%-3.85%+72.41%-28.16%
Nuwellis, Inc. stock logo
NUWE
Nuwellis
-6.26%-32.82%-42.26%-41.47%-94.07%
Positron Co. stock logo
POSC
Positron
+4.55%-2.34%-11.54%-23.33%-28.39%
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
-2.39%-5.34%-4.56%-12.35%+9.34%
Viveve Medical, Inc. stock logo
VIVE
Viveve Medical
0.00%-33.33%0.00%0.00%-99.57%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Micron Solutions, Inc. stock logo
MICR
Micron Solutions
N/AN/AN/AN/AN/AN/AN/AN/A
Nuwellis, Inc. stock logo
NUWE
Nuwellis
N/AN/AN/AN/AN/AN/AN/AN/A
Positron Co. stock logo
POSC
Positron
N/AN/AN/AN/AN/AN/AN/AN/A
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
1.2326 of 5 stars
0.04.00.00.00.03.31.9
Viveve Medical, Inc. stock logo
VIVE
Viveve Medical
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Micron Solutions, Inc. stock logo
MICR
Micron Solutions
N/AN/AN/AN/A
Nuwellis, Inc. stock logo
NUWE
Nuwellis
2.00
HoldN/AN/A
Positron Co. stock logo
POSC
Positron
N/AN/AN/AN/A
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
N/AN/AN/AN/A
Viveve Medical, Inc. stock logo
VIVE
Viveve Medical
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Micron Solutions, Inc. stock logo
MICR
Micron Solutions
$22.57M0.19N/AN/A$1.38 per share0.91
Nuwellis, Inc. stock logo
NUWE
Nuwellis
$8.86M0.20N/AN/A$0.53 per share0.48
Positron Co. stock logo
POSC
Positron
$740K40.30N/AN/A($0.04) per share-28.75
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
$45.78M0.30$0.07 per share12.06$2.93 per share0.29
Viveve Medical, Inc. stock logo
VIVE
Viveve Medical
$6.43M0.00N/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Micron Solutions, Inc. stock logo
MICR
Micron Solutions
-$1.29M-$0.43N/AN/AN/AN/AN/AN/A
Nuwellis, Inc. stock logo
NUWE
Nuwellis
-$20.21M-$13.46N/AN/AN/A-227.99%-218.79%-140.88%5/14/2024 (Estimated)
Positron Co. stock logo
POSC
Positron
-$1.64MN/A0.00N/A-222.99%N/A-65.25%N/A
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
$25.13M$1.470.59N/A42.49%-0.33%-0.18%5/20/2024 (Estimated)
Viveve Medical, Inc. stock logo
VIVE
Viveve Medical
-$22.03MN/A0.00N/AN/AN/AN/AN/A

Latest NUWE, VIVE, STRR, POSC, and MICR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/22/2024Q4 2023
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
-$0.03-$0.02+$0.01-$0.12$9.00 million$14.11 million
3/5/202412/31/2023
Nuwellis, Inc. stock logo
NUWE
Nuwellis
-$1.39-$2.24-$0.85-$2.24N/A$2.55 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Micron Solutions, Inc. stock logo
MICR
Micron Solutions
N/AN/AN/AN/AN/A
Nuwellis, Inc. stock logo
NUWE
Nuwellis
N/AN/AN/AN/AN/A
Positron Co. stock logo
POSC
Positron
N/AN/AN/AN/AN/A
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
N/AN/AN/AN/AN/A
Viveve Medical, Inc. stock logo
VIVE
Viveve Medical
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Micron Solutions, Inc. stock logo
MICR
Micron Solutions
N/AN/AN/A
Nuwellis, Inc. stock logo
NUWE
Nuwellis
N/A
2.59
1.96
Positron Co. stock logo
POSC
Positron
N/A
0.70
0.06
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
N/A
3.99
3.59
Viveve Medical, Inc. stock logo
VIVE
Viveve Medical
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Micron Solutions, Inc. stock logo
MICR
Micron Solutions
N/A
Nuwellis, Inc. stock logo
NUWE
Nuwellis
3.13%
Positron Co. stock logo
POSC
Positron
N/A
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
3.84%
Viveve Medical, Inc. stock logo
VIVE
Viveve Medical
N/A

Insider Ownership

CompanyInsider Ownership
Micron Solutions, Inc. stock logo
MICR
Micron Solutions
26.10%
Nuwellis, Inc. stock logo
NUWE
Nuwellis
0.88%
Positron Co. stock logo
POSC
Positron
17.20%
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
28.83%
Viveve Medical, Inc. stock logo
VIVE
Viveve Medical
5.73%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Micron Solutions, Inc. stock logo
MICR
Micron Solutions
823.44 million2.54 millionNot Optionable
Nuwellis, Inc. stock logo
NUWE
Nuwellis
596.80 million6.74 millionNot Optionable
Positron Co. stock logo
POSC
Positron
1925.93 million21.47 millionNot Optionable
Star Equity Holdings, Inc. stock logo
STRR
Star Equity
17115.85 million11.28 millionNot Optionable
Viveve Medical, Inc. stock logo
VIVE
Viveve Medical
4710.72 million10.11 millionNot Optionable

NUWE, VIVE, STRR, POSC, and MICR Headlines

SourceHeadline
5-Alpha Reductase Deficiency Global Market Report 2024: A $1.94 Billion Projected Market in 20285-Alpha Reductase Deficiency Global Market Report 2024: A $1.94 Billion Projected Market in 2028
finance.yahoo.com - April 17 at 6:28 PM
InMode Responds To BTL Petition for Inter Partes Review Of Patent InMode Is Asserting Against BTLInMode Responds To BTL Petition for Inter Partes Review Of Patent InMode Is Asserting Against BTL
finance.yahoo.com - April 15 at 7:58 AM
Viveve Medical Stock (OTC:VIVE), Analyst Ratings, Price Targets, PredictionsViveve Medical Stock (OTC:VIVE), Analyst Ratings, Price Targets, Predictions
benzinga.com - February 23 at 10:31 AM
The Best Medical Billing Services of 2024The Best Medical Billing Services of 2024
business.com - January 19 at 10:31 PM
VIVE Viveve Medical, Inc.VIVE Viveve Medical, Inc.
seekingalpha.com - July 29 at 9:53 AM
InMode Expands Womens Health and Wellness Market Footprint through Acquisition of Viveve PatentsInMode Expands Women's Health and Wellness Market Footprint through Acquisition of Viveve Patents
finance.yahoo.com - July 25 at 9:01 AM
VIVE - Viveve Medical, Inc.VIVE - Viveve Medical, Inc.
uk.finance.yahoo.com - June 14 at 7:59 PM
Viveve Medical, Inc. (VIVE)Viveve Medical, Inc. (VIVE)
finance.yahoo.com - February 24 at 8:19 AM
Viveve Medical announces study result from PURSUIT clinical trial to treat female stress urinary incontinenceViveve Medical announces study result from PURSUIT clinical trial to treat female stress urinary incontinence
pharmabiz.com - January 20 at 9:26 AM
Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesdays Mid-Day SessionWhy Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
msn.com - January 17 at 3:40 PM
Viveve Medical, Inc.: Viveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary IncontinenceViveve Medical, Inc.: Viveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence
finanznachrichten.de - January 17 at 10:39 AM
Viveve crashes ~60% as company decides to delist, explore sale after trial failsViveve crashes ~60% as company decides to delist, explore sale after trial fails
seekingalpha.com - January 17 at 10:39 AM
Viveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary IncontinenceViveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence
finance.yahoo.com - January 17 at 10:39 AM
Viveve Medical Seeks Strategic Alternatives After Failed Stress Urinary Incontinence TrialViveve Medical Seeks Strategic Alternatives After Failed Stress Urinary Incontinence Trial
finance.yahoo.com - January 17 at 10:39 AM
Why Is Viveve Medical (VIVE) Stock Down 69% Today?Why Is Viveve Medical (VIVE) Stock Down 69% Today?
investorplace.com - January 17 at 10:03 AM
Viveve Medical, Inc. (NASDAQ:VIVE) Q3 2022 Earnings Call TranscriptViveve Medical, Inc. (NASDAQ:VIVE) Q3 2022 Earnings Call Transcript
insidermonkey.com - December 29 at 9:56 AM
Viveve Announces Completion of Pivotal US PURSUIT Trial for Female Stress Urinary Incontinence with Final 12-month Follow-up Visits ConcludedViveve Announces Completion of Pivotal US PURSUIT Trial for Female Stress Urinary Incontinence with Final 12-month Follow-up Visits Concluded
finance.yahoo.com - December 15 at 10:21 AM
Viveve gets US patent for treating female stress urinary incontinenceViveve gets US patent for treating female stress urinary incontinence
pharmabiz.com - December 3 at 7:46 AM
Viveve Medical, Inc.: Viveve Announces Issuance of Second U.S. Method Patent for Treating Female Stress Urinary IncontinenceViveve Medical, Inc.: Viveve Announces Issuance of Second U.S. Method Patent for Treating Female Stress Urinary Incontinence
finanznachrichten.de - December 1 at 12:46 PM
Viveve Announces Issuance of Second U.S. Method Patent for Treating Female Stress Urinary IncontinenceViveve Announces Issuance of Second U.S. Method Patent for Treating Female Stress Urinary Incontinence
finance.yahoo.com - December 1 at 12:46 PM
Viveve Medical Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues LagViveve Medical Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag
finance.yahoo.com - November 13 at 7:01 PM
InvestorNewsBreaks — Viveve Medical Inc. (NASDAQ: VIVE) Releases Q3 2022 Financial Report, Corporate UpdateInvestorNewsBreaks — Viveve Medical Inc. (NASDAQ: VIVE) Releases Q3 2022 Financial Report, Corporate Update
markets.buffalonews.com - November 12 at 7:52 AM
Viveve Medical, Inc.: Viveve Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateViveve Medical, Inc.: Viveve Reports Third Quarter 2022 Financial Results and Provides Corporate Update
finanznachrichten.de - November 10 at 4:16 PM
Viveve Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateViveve Reports Third Quarter 2022 Financial Results and Provides Corporate Update
finance.yahoo.com - November 10 at 4:16 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Micron Solutions logo

Micron Solutions

OTCMKTS:MICR
Micron Solutions, Inc. operates as a contract manufacturer for the medical device, defense, and life sciences markets. It offers precision machining, thermoplastic injection molding, mold making products; sensors; orthopedic implants and devices; and diagnostic test kits. The company provides solutions for medical, orthopedics, consumer, and automotive industries. Micron Solutions, Inc. was founded in 1978 and is based in Fitchburg, Massachusetts.
Nuwellis logo

Nuwellis

NASDAQ:NUWE
Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama. Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Positron logo

Positron

OTCMKTS:POSC
Positron Corporation, a nuclear medicine healthcare company, specializes in the business of cardiac positron emission tomography (PET) imaging in the United States. It offers attrius PET scanner, clinical and technical services, and financing solutions enables healthcare providers to accurately diagnose cardiac disease, improve patient outcomes, and practice cost effective medicines. Positron Corporation was incorporated in 1983 and is based in Niagara Falls, New York.
Star Equity logo

Star Equity

NASDAQ:STRR
Star Equity Holdings, Inc. engages in the construction business in the United States and internationally. It operates through two segments: Construction, and Investments. It manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; holds real estate assets; and manages investments. The company was formerly known as Digirad Corporation and changed its name to Star Equity Holdings, Inc. in December 2020. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Old Greenwich, Connecticut.
Viveve Medical logo

Viveve Medical

NASDAQ:VIVE
Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.